(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide

C55H64ClFN14O6 — CID 156524451

IUPAC(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide
SMILESCCC[C@@H](NC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1ncc(CCC(NC(=O)N2C(=O)[C@H](Cc3cc(C)nc(N)c3)[C@H]2C(=O)N(C)c2nccn2C)c2cc(C)ccc2Cl)n1C)c1cc(C)ccc1F
InChIInChI=1S/C55H64ClFN14O6/c1-10-11-42(37-21-30(3)13-16-41(37)57)64-54(76)71-47(39(49(71)73)25-34-23-32(5)63-45(59)27-34)51(75)69(9)53-61-28-35(67(53)7)14-17-43(36-20-29(2)12-15-40(36)56)65-55(77)70-46(50(74)68(8)52-60-18-19-66(52)6)38(48(70)72)24-33-22-31(4)62-44(58)26-33/h12-13,15-16,18-23,26-28,38-39,42-43,46-47H,10-11,14,17,24-25H2,1-9H3,(H2,58,62)(H2,59,63)(H,64,76)(H,65,77)/t38-,39-,42-,43?,46+,47+/m1/s1
InChIKeyWEAJDVVEYIFHML-DTZLCLSZSA-N
MW1071.66 g/mol
LogP6.53
Rot. Bonds17

About (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide

(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide (PubChem CID 156524451) has the molecular formula C55H64ClFN14O6 and a molecular weight of 1071.66 g/mol. Its IUPAC name is (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide.

Molecular Properties

Compound Name(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide
PubChem CID156524451
Molecular FormulaC55H64ClFN14O6
Molecular Weight1071.66 g/mol
Exact Mass1070.48
IUPAC Name(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide
SMILESCCC[C@@H](NC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1ncc(CCC(NC(=O)N2C(=O)[C@H](Cc3cc(C)nc(N)c3)[C@H]2C(=O)N(C)c2nccn2C)c2cc(C)ccc2Cl)n1C)c1cc(C)ccc1F
InChIInChI=1S/C55H64ClFN14O6/c1-10-11-42(37-21-30(3)13-16-41(37)57)64-54(76)71-47(39(49(71)73)25-34-23-32(5)63-45(59)27-34)51(75)69(9)53-61-28-35(67(53)7)14-17-43(36-20-29(2)12-15-40(36)56)65-55(77)70-46(50(74)68(8)52-60-18-19-66(52)6)38(48(70)72)24-33-22-31(4)62-44(58)26-33/h12-13,15-16,18-23,26-28,38-39,42-43,46-47H,10-11,14,17,24-25H2,1-9H3,(H2,58,62)(H2,59,63)(H,64,76)(H,65,77)/t38-,39-,42-,43?,46+,47+/m1/s1
InChIKeyWEAJDVVEYIFHML-DTZLCLSZSA-N
XLogP6.53
TPSA252.90 Ų
H-Bond Donors4
H-Bond Acceptors14
Rotatable Bonds17
Heavy Atoms77
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001071.66
LogP ≤ 56.53
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1014

Analyze (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide?
The IUPAC name of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide (CID 156524451) is (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide.
What is the SMILES notation for (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide?
The canonical SMILES for (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide is CCC[C@@H](NC(=O)N1C(=O)[C@H](Cc2cc(C)nc(N)c2)[C@H]1C(=O)N(C)c1ncc(CCC(NC(=O)N2C(=O)[C@H](Cc3cc(C)nc(N)c3)[C@H]2C(=O)N(C)c2nccn2C)c2cc(C)ccc2Cl)n1C)c1cc(C)ccc1F.
What is the InChIKey of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide?
The InChIKey is WEAJDVVEYIFHML-DTZLCLSZSA-N. The full InChI is InChI=1S/C55H64ClFN14O6/c1-10-11-42(37-21-30(3)13-16-41(37)57)64-54(76)71-47(39(49(71)73)25-34-23-32(5)63-45(59)27-34)51(75)69(9)53-61-28-35(67(53)7)14-17-43(36-20-29(2)12-15-40(36)56)65-55(77)70-46(50(74)68(8)52-60-18-19-66(52)6)38(48(70)72)24-33-22-31(4)62-44(58)26-33/h12-13,15-16,18-23,26-28,38-39,42-43,46-47H,10-11,14,17,24-25H2,1-9H3,(H2,58,62)(H2,59,63)(H,64,76)(H,65,77)/t38-,39-,42-,43?,46+,47+/m1/s1.
What are the key properties of (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide?
(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide has a molecular weight of 1071.66 g/mol, XLogP of 6.53, 17 rotatable bonds, 4 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for (2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-N-[3-[2-[[(2S,3R)-3-[(2-amino-6-methyl-4-pyridinyl)methyl]-1-[[(1R)-1-(2-fluoro-5-methylphenyl)butyl]carbamoyl]-4-oxoazetidine-2-carbonyl]-methylamino]-3-methylimidazol-4-yl]-1-(2-chloro-5-methylphenyl)propyl]-2-N-methyl-2-N-(1-methylimidazol-2-yl)-4-oxoazetidine-1,2-dicarboxamide is sourced from PubChem (CID 156524451), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).